Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Trends in Biotechnology|July 31, 2004
What is disrupting IFN-alpha's antiviral activity?M Lamine Mbow, Robert T SariskyDrug News & Perspectives|May 26, 2005
Modulating toll-like receptor signalling as a novel antiinfective approachM Lamine Mbow, Robert T SariskyCurrent Opinion in Immunology|May 15, 2010
New adjuvants for human vaccinesM Lamine Mbow, Ennio De Gregorio, Nicholas M Valiante, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Identification and characterization of novel bone marrow myeloid DEC205+Gr-1+ cell subsets that differentially express chemokine and TLRsRoberta J Lamb, Renold J Capocasale, Karen E Duffy, et al.The American Journal of Tropical Medicine and Hygiene|December 26, 2003
Short report: requirement of b cells for delayed type hypersensitivity-like pathology after secondary infection with Leishmania major in resistant C57BL/6 miceGregory K DeKrey, Jeremy J Jones, M Lamine Mbow, et al.Journal of Innate Immunity|November 28, 2017
E3 Ubiquitin Ligase RNF125 Activates Interleukin-36 Receptor Signaling and Contributes to Its TurnoverSiddhartha S Saha, Gary Caviness, Guanghui Yi, et al.Journal of Medical Microbiology|June 17, 2003
Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferiRobert D Gilmore, Rendi M Bacon, Amber M Carpio, et al.Hybridoma and Hybridomics|August 8, 2002
Borrelia burgdorferi-specific monoclonal antibodies derived from mice primed with Lyme disease spirochete-infected Ixodes scapularis ticksM Lamine Mbow, Robert D Gilmore, Brian Stevenson, et al.FEMS Microbiology Letters|May 15, 2002
Type 1 and type 2 responses to Leishmania majorKathleen A Rogers, Gregory K DeKrey, M Lamine Mbow, et al.Infection and Immunity|September 24, 2004
Borrelia burgdorferi changes its surface antigenic expression in response to host immune responsesFang Ting Liang, Jun Yan, M Lamine Mbow, et al.Pageof 5